Skip to main content
Study begins for Medtronic's Arctic Front Advance cryoballoon
7/12/2017

The first patient in a prospective, randomized, controlled trial of Medtronic's Arctic Front Advance cryoballoon has been enrolled at The Ohio State University Wexner Medical Center. The 210-patient, 30-site US trial seeks to assess use of the device as a first-line treatment for symptomatic paroxysmal atrial fibrillation, compared with antiarrhythmic drug therapy, for 12 months.

Full Story: